AI assistant
Sending…
BIODESIX INC — Director's Dealing 2021
Jul 2, 2021
34472_dirs_2021-07-01_af33c5c6-a954-4f93-90f8-1ebe49fa61dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2021-06-29
Reporting Person: Watts Charles M (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-29 | Stock Options (Right to buy) | $13.72 | A | 34385 | Acquired | 2031-06-28 | Common Stock (34385) | Direct |
Footnotes
F1: This option will vest in full on March 31, 2022.
More from BIODESIX INC
Registration Form
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23